Literature DB >> 7682460

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.

K Blennow1, A Wallin, C G Gottfries, I Karlsson, J E Månsson, I Skoog, C Wikkelsö, L Svennerholm.   

Abstract

Concentrations of the monoamine metabolites homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA) and 4-hydroxy-3-methoxyphenylglycol (HMPG) were determined in lumbar cerebrospinal fluid (CSF) of 114 healthy individuals, 18-88 years of age, without histories, symptoms or signs of central nervous system dysfunction. The mean values (+/- SD) were 253 +/- 109 nmol/l for HVA, 125 +/- 54 nmol/l for 5-HIAA, 47 +/- 10 nmol/l for HMPG, and 2.10 +/- 0.52 for the HVA/5-HIAA ratio. Analyses of confounding factors revealed that all metabolites correlated negatively with body height, the values being lower in taller than in shorter individuals. This is probably attributable to a larger surface area for monoamine metabolite transport from the subarachnoid space in taller than in shorter individuals. These correlations make statistical adjustment for body height important in analyses of monoamine metabolite levels. Without considering body height, all monoamine metabolites showed a positive correlation with age, and higher levels of HVA and 5-HIAA were found in women than men. After statistical adjustment for the influence of body height, no differences in CSF monoamine metabolites levels were found between the sexes, and only 5-HIAA showed a positive correlation with age. There were no significant seasonal variations for any of the monoamine metabolites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682460     DOI: 10.1016/0924-977x(93)90295-w

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.

Authors:  Sven Pålhagen; Hongshi Qi; Björn Mårtensson; Jan Wålinder; Ann-Kathrine Granérus; Per Svenningsson
Journal:  J Neurol       Date:  2009-10-21       Impact factor: 4.849

Review 2.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

3.  Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.

Authors:  A Thiel; D Dressler; A Reimer; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1994

4.  Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD.

Authors:  Eleonore Rydén; Christian Johansson; Kaj Blennow; Mikael Landén
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

5.  New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits.

Authors:  H Soderstrom; K Blennow; A-K Sjodin; A Forsman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

6.  Non-neurological surgery results in a neurochemical stress response.

Authors:  R Anckarsäter; H Zetterberg; J-E Månsson; K Blennow; H Anckarsäter
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

7.  Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms.

Authors:  Heidi I L Jacobs; Joost M Riphagen; Inez H G B Ramakers; Frans R J Verhey
Journal:  Mol Psychiatry       Date:  2019-05-28       Impact factor: 15.992

8.  Sex and race differences of cerebrospinal fluid metabolites in healthy individuals.

Authors:  Zackery W Reavis; Nikhil Mirjankar; Srikant Sarangi; Stephen H Boyle; Cynthia M Kuhn; Wayne R Matson; Michael A Babyak; Samantha A Matson; Ilene C Siegler; Rima Kaddurah-Daouk; Edward C Suarez; Redford B Williams; Katherine Grichnik; Mark Stafford-Smith; Anastasia Georgiades
Journal:  Metabolomics       Date:  2021-01-18       Impact factor: 4.290

9.  A Metabolomic Aging Clock Using Human Cerebrospinal Fluid.

Authors:  Nathan Hwangbo; Xinyu Zhang; Daniel Raftery; Haiwei Gu; Shu-Ching Hu; Thomas J Montine; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Dongfang Wang; Qiang Fei; Lisa Bettcher; Cyrus P Zabetian; Elaine Peskind; Gail Li; Daniel E L Promislow; Alexander Franks
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

10.  Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.

Authors:  Erik Pålsson; Carl Sellgren; Eleonore Rydén; Ruth Kizza; Aurimantas Pelanis; Henrik Zetterberg; Kaj Blennow; Mikael Landén
Journal:  J Neural Transm (Vienna)       Date:  2017-06-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.